跳至主要内容
临床试验/NCT06776939
NCT06776939招募中不适用

Physiological Effect High-flow Tracheal Oxygen on Viscosity of Airway Mucus and Respiratory Effort in Patients Weaning from Invasive Mechanical Ventilation

Henrik Endeman1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2025年1月6日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
20
试验地点
1
主要终点
Sputum viscoelasticity

研究概览

简要总结

Rationale: Tracheostomized patients weaning from mechanical ventilation are at risk for dryness of airway mucosa and sputum accumulation during disconnection from mechanical ventilation. High-flow tracheal oxygen (HFTO) is being used as supportive therapy during disconnection sessions in tracheostomized patients weaning from invasive mechanical ventilation (IMV) to limit dryness while maintaining oxygenation. We recently summarized the studies comparing physiological effects HFTO as compared to other interfaces, collectively referred to as conventional oxygen therapy (COT), in a systematic review and identified areas of lacking knowledge: effect on sputum viscoelasticity, respiratory effort early in the weaning process and dyspnea sensation. We hypothesize that HFTO, compared to COT, decreases viscoelasticity of the sputum and provides respiratory support during weaning. This may improve weaning by facilitating clearance of airway mucus, preventing respiratory failure, and providing comfort by decreasing dyspnea.

Objective: To determine the physiological effect of HFTO compared to COT on sputum viscoelasticity, respiratory effort and dyspnoea.

Study design: Pilot study with randomized crossover design, single-center. Study population: Twenty adult patients weaning from mechanical ventilation with tracheostomy.

Intervention (if applicable): Crossover with COT and HFTO during two days in the weaning phase.

Main study parameters/endpoints: Primary endpoint: sputum viscoelasticity measured by rheology during long disconnection sessions in the final phase of weaning. Secondary endpoints: respiratory effect measured by swings in esophageal pressure (PES) and prevalence and severity of dyspnoea sensation by visual analogue scale (VAS).

Nature and extent of the burden and risks associated with participation, benefit and group relatedness: The study compares two therapeutic modalities both used in clinical care without side-effects or complications. Study procedures and measurements consist of standard clinical procedures that are performed daily in clinical setting with negligible risk of deterioration for the patient. During weaning with HFTO sputum clearance might be more easy for the patient and respiratory effort might decrease, both are assumed to be beneficial for the weaning process of the patient.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Age ≥18 years
  • •Weaning from mechanical ventilation with tracheostomy

排除标准

  • •Longstanding tracheostomy, defined as tracheostomy being present prior to current hospital admission
  • •Tracheostomy primarily indicated for chronic upper airway obstruction or to secure airway patency due to persistent stupor/coma
  • •Chronic positive pressure respiratory support at home (excluding night-time continuous positive airway pressure for sleep apnea)
  • •Mucociliary disease in medical history (e.g. cystic fibrosis, pulmonary ciliary dyskinesia)
  • •Neuromuscular disease in medical history (excluding ICU-acquired weakness)
  • •Contra-indication placement oesophageal balloon for measurement of PES, such as:
  • •Fractures in mandibular, orbital or ethmoid bone or skull base
  • •Esophageal varices or surgery in medical history
  • •Severe bleeding disorders
  • •Hemoptysis in 72 hours prior to the first disconnection session. Clinically relevant hemoptysis is defined as hemoptysis requiring tracheal/endobronchial or radiologic intervention, or administration of pro-coagulating drugs such as tranexamic acid.

研究组 & 干预措施

First conventional oxygen therapy, then high-flow tracheal oxygen

Active Comparator

The disconnection sessions on the days with study measurements are started with conventional oxygen therapy, and the second disconnection session is supported with high-flow tracheal oxygen. Conventional oxygen therapy is provided using a heat-moisture exchanger.

干预措施: Oxygen therapy (Device)

First high-flow tracheal oxygen, then conventional oxygen therapy

Active Comparator

The disconnection sessions on the days with study measurements are started with high-flow tracheal oxygen, and the second disconnection session is supported with conventional oxygen therapy. Conventional oxygen therapy is provided using a heat-moisture exchanger.

干预措施: Oxygen therapy (Device)

结局指标

主要结局

Sputum viscoelasticity

时间窗: The 12-hour disconnection session

During disconnection from the ventilator patients do not breathe actively heated and humidified gas mixtures. During disconnection from the ventilator the airway mucus thickens. This thickening can be quantified by measuring visco-elasticity and at the end of the disconnection sessions. The change in visco-elasticity between the start and end of the disconnection session will be compared within patients between disconnection sessions with HME and HFTO. Hence, the primary end-point is the change in sputum viscoelasticity from baseline to the end of the long disconnection sessions (≥12 hours). Viscoelastic (G\*) is made up of elasticity (G') and viscosity (G'') of mucus at a 5% strain rate (or linear viscoelastic region, which reflects the small deformation regime) and the critical stress (σ critical)· and strain (y critical) of mucus, which reflect the behavior of mucus under high amounts of shear stress and thus the large deformation regime.

次要结局

  • Sputum visco-elasiticity(The short disconnection session (<90 minutes))
  • Dyspnea presence(At early (<90 min) and late (12 hour) disconnection sessions)
  • Respiratory effort(The short disconnection session (<90 minutes))
  • Dyspnea severity(early (<90 min) and late (12 hour) disconnection sessions)

研究者

发起方
Henrik Endeman
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Henrik Endeman

Intensivist, Assistant professor Intensive Care

Erasmus Medical Center

研究点 (1)

Loading locations...

相似试验